Literature DB >> 12324259

Drosophila melanogaster as a model system for drug discovery and pathway screening.

Sanjay Tickoo1, Steven Russell.   

Abstract

Although the freakish nightmare world of Mr Samsa may seem completely divorced from our view of the real world, the comparisons between the Drosophila and human genomes indicate that we are a lot closer to insects than we like to think. The use of sophisticated genetic approaches combined with emerging genomics technologies suggest that the fly has much to offer as a tool for understanding basic cellular processes and provides an attractive and complex model system for exploring the molecular basis of human diseases such as cancer, Alzheimer's disease and Huntington's disease.

Entities:  

Mesh:

Year:  2002        PMID: 12324259     DOI: 10.1016/s1471-4892(02)00206-0

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  14 in total

1.  Fluorescence-activated cell sorting (FACS) of Drosophila hemocytes reveals important functional similarities to mammalian leukocytes.

Authors:  Rabindra Tirouvanziam; Colin J Davidson; Joseph S Lipsick; Leonard A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

Review 2.  Genomic RNAi screening in Drosophila S2 cells: what have we learned about host-pathogen interactions?

Authors:  Sara Cherry
Journal:  Curr Opin Microbiol       Date:  2008-06-06       Impact factor: 7.934

3.  On chip cryo-anesthesia of Drosophila larvae for high resolution in vivo imaging applications.

Authors:  Amrita Ray Chaudhury; Ryan Insolera; Ran-Der Hwang; Yih-Woei Fridell; Catherine Collins; Nikos Chronis
Journal:  Lab Chip       Date:  2017-06-27       Impact factor: 6.799

4.  Seizure suppression by gain-of-function escargot mutations.

Authors:  Daria S Hekmat-Scafe; Kim N Dang; Mark A Tanouye
Journal:  Genetics       Date:  2005-01-16       Impact factor: 4.562

5.  Characterization of microfluidic clamps for immobilizing and imaging of Drosophila melanogaster larva's central nervous system.

Authors:  Reza Ghaemi; Pouya Rezai; Fatemeh Rafiei Nejad; Ponnambalam Ravi Selvaganapathy
Journal:  Biomicrofluidics       Date:  2017-05-26       Impact factor: 2.800

6.  Animal models of autism spectrum disorders: information for neurotoxicologists.

Authors:  Alycia K Halladay; David Amaral; Michael Aschner; Valerie J Bolivar; Aaron Bowman; Emanuel DiCicco-Bloom; Susan L Hyman; Flavio Keller; Pamela Lein; Isaac Pessah; Linda Restifo; David W Threadgill
Journal:  Neurotoxicology       Date:  2009-07-09       Impact factor: 4.294

Review 7.  From bench to drug: human seizure modeling using Drosophila.

Authors:  Juan Song; Mark A Tanouye
Journal:  Prog Neurobiol       Date:  2007-10-26       Impact factor: 11.685

Review 8.  Drosophila melanogaster as a genetic model system to study neurotransmitter transporters.

Authors:  Ciara A Martin; David E Krantz
Journal:  Neurochem Int       Date:  2014-04-03       Impact factor: 3.921

9.  Testing the therapeutic potential of doxycycline in a Drosophila melanogaster model of Alzheimer disease.

Authors:  Rita Costa; Elena Speretta; Damian C Crowther; Isabel Cardoso
Journal:  J Biol Chem       Date:  2011-10-13       Impact factor: 5.157

10.  The NADPH metabolic network regulates human αB-crystallin cardiomyopathy and reductive stress in Drosophila melanogaster.

Authors:  Heng B Xie; Anthony Cammarato; Namakkal S Rajasekaran; Huali Zhang; Jennifer A Suggs; Ho-Chen Lin; Sanford I Bernstein; Ivor J Benjamin; Kent G Golic
Journal:  PLoS Genet       Date:  2013-06-20       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.